Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Fujicco Co. Ltd. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The prosecution is highly centralized, as evidenced by the involvement of only 1 distinct examiner and 1 distinct art unit. This streamlined profile indicates that the portfolio's current momentum is tied to a point of review within the USPTO. Such a structure minimizes the risk of inconsistent examiner treatment across the company's intellectual property assets and allows for a very focused management style.
The busiest examiner identified is CHEN, CATHERYNE, who is overseeing 1 pending office action. Because this represents the total active volume for the portfolio, the examiner's specific tendencies will heavily influence the immediate results. The lack of multiple examiners or art units simplifies the management of these assets. For the applicant, this means that the prosecution strategy can be entirely customized to the feedback received from this examiner, ensuring a consistent response to any raised objections. This high level of concentration makes the examiner's previous allowance rates and common rejection types particularly relevant.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHEN, CATHERYNE | 1 | 37.5% | +17.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17898960 | PSYCHOLOGICAL FATIGUE PREVENTER OR IMPROVER | CHEN, CATHERYNE | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17898960 | PSYCHOLOGICAL FATIGUE PREVENTER OR IMPROVER | CHEN, CATHERYNE | 1655 | §102 | Non-Final OA | — | Pending | Aug 30, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFujicco Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Catheryne Chen has the most, with 1 of Fujicco Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
